文献速递儿科与产科急症

41周引产与期待管理至42周(INDEX):多中心随机非劣效性试验

Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.
PubMed 文献 · BMJ · 2019-02-20
一句话结论低危单胎妊娠41周引产较期待管理至42周降低不良围产结局风险1.4%,但两种策略围产结局良好几率均高。

荷兰123个初级助产机构和45家医院开展开放标签随机非劣效性试验,纳入1801例低危单胎妊娠孕妇,随机分为41周引产组(n=900)和期待管理至42周组(n=901)。主要复合终点为围产死亡和新生儿并发症。引产组15/900(1.7%)发生不良围产结局,期待管理组28/901(3.1%),绝对风险差-1.4%(95%CI -2.9%至0.0%,非劣效性P=0.22),未能证明期待管理非劣效于引产。引产组5分钟Apgar评分<7分者11例(1.2%),期待管理组23例(2.6%)(RR 0.48,95%CI 0.23至0.98)。结论认为两种策略围产结局良好几率均高,围产死亡率、5分钟Apgar评分<4分和NICU入住率均低。

要点

  • 低危单胎妊娠41周引产组不良围产结局1.7%(15/900),期待管理至42周组3.1%(28/901),绝对风险差-1.4%(95%CI -2.9%至0.0%),非劣效性检验P=0.22,未能证明期待管理非劣效。
  • 引产组5分钟Apgar评分<7分11例(1.2%)低于期待管理组23例(2.6%),RR 0.48(95%CI 0.23至0.98)。
  • 引产组无5分钟Apgar评分<4分婴儿,期待管理组3例(0.3%);围产儿死亡引产组1例(0.1%),期待管理组2例(0.2%);无新生儿死亡。
  • 引产组NICU入住3例(0.3%),期待管理组8例(0.9%),RR 0.38(95%CI 0.10至1.41)。
  • 复合不良母体结局引产组122例(13.6%)与期待管理组102例(11.3%)无显著差异,剖宫产率两组均为97例(10.8%)。

适用人群与场景

  • 荷兰123个初级助产机构和45家医院(二级保健)的低危孕妇,单胎妊娠无并发症,孕周至41周。
  • 纳入2012至2016年,随机分为41周引产组(n=900)或期待管理至42周组(n=901)。

处置流程与药物剂量

  • 引产组于41周引产。
  • 期待管理组期待管理至42周,必要时引产。

研究设计与关键结果

  • 开放标签随机对照非劣效性试验,纳入1801例低危单胎妊娠孕妇,引产组900例,期待管理组901例。
  • 主要复合终点(围产死亡和新生儿并发症:5分钟Apgar评分<7分、动脉血pH<7.05、胎粪吸入综合征、臂丛神经损伤、颅内出血、NICU入住)引产组15/900(1.7%)vs 期待管理组28/901(3.1%),绝对风险差-1.4%(95%CI -2.9%至0.0%),非劣效性P=0.22。
  • 5分钟Apgar评分<7分:引产组11例(1.2%)vs 期待管理组23例(2.6%),RR 0.48(95%CI 0.23至0.98)。
  • 5分钟Apgar评分<4分:引产组0例 vs 期待管理组3例(0.3%)。
  • 围产儿死亡:引产组1例(0.1%)vs 期待管理组2例(0.2%);无新生儿死亡。
  • NICU入住:引产组3例(0.3%)vs 期待管理组8例(0.9%),RR 0.38(95%CI 0.10至1.41)。
  • 复合不良母体结局:引产组122例(13.6%)vs 期待管理组102例(11.3%),无显著差异;剖宫产率两组均为97例(10.8%)。
  • 分娩时中位孕周:引产组41周+0天(四分位距41周+0天至41周+1天),期待管理组41周+2天(四分位距41周+0天至41周+5天)。

证据类型、等级与局限

  • 证据类型:开放标签、随机对照非劣效性试验。
  • 非劣效性界值2%。
  • 作者结论:未能证明期待管理非劣效于41周引产,反而发现不良围产结局风险差异1.4%有利于引产,但两种策略围产结局良好几率均高,围产死亡率、5分钟Apgar评分<4分和NICU入住率均低。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于低危单胎妊娠无并发症孕妇,41周引产与期待管理至42周均可采用,两者围产结局良好几率均高,围产死亡率、5分钟Apgar评分<4分和NICU入住率均低。
  • 作者结论指出本研究未能证明期待管理非劣效于41周引产,不良围产结局风险差异1.4%有利于引产。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To compare induction of labour at 41 weeks with expectant management until 42 weeks in low risk women.

DESIGN: Open label, randomised controlled non-inferiority trial.

SETTING: 123 primary care midwifery practices and 45 hospitals (secondary care) in the Netherlands, 2012-16.

PARTICIPANTS: 1801 low risk women with an uncomplicated singleton pregnancy: randomised to induction (n=900) or to expectant management until 42 weeks (n=901).

INTERVENTIONS: Induction at 41 weeks or expectant management until 42 weeks with induction if necessary.

PRIMARY OUTCOME MEASURES: Primary outcome was a composite of perinatal mortality and neonatal morbidity (Apgar score <7 at five minutes, arterial pH <7.05, meconium aspiration syndrome, plexus brachialis injury, intracranial haemorrhage, and admission to a neonatal intensive care unit (NICU). Secondary outcomes included maternal outcomes and mode of delivery. The null hypothesis that expectant management is inferior to induction was tested with a non-inferiority margin of 2%.

RESULTS: Median gestational age at delivery was 41 weeks+0 days (interquartile range 41 weeks+0 days-41 weeks+1 day) for the induction group and 41 weeks+2 days (41 weeks+0 days-41 weeks+5 days) for the expectant management group. The primary outcome was analysed for both the intention-to-treat population and the per protocol population. In the induction group, 15/900 (1.7%) women had an adverse perinatal outcome versus 28/901 (3.1%) in the expectant management group (absolute risk difference -1.4%, 95% confidence interval -2.9% to 0.0%, P=0.22 for non-inferiority). 11 (1.2%) infants in the induction group and 23 (2.6%) in the expectant management group had an Apgar score <7 at five minutes (relative risk (RR) 0.48, 95% CI 0.23 to 0.98). No infants in the induction group and three (0.3%) in the expectant management group had an Apgar score <4 at five minutes. One fetal death (0.1%) occurred in the induction group and two (0.2%) in the expectant management group. No neonatal deaths occurred. 3 (0.3%) neonates in the induction group versus 8 (0.9%) in the expectant management group were admitted to an NICU (RR 0.38, 95% CI 0.10 to 1.41). No significant difference was found in composite adverse maternal outcomes (induction n=122 (13.6%) v expectant management n=102 (11.3%)) or in caesarean section rate (both groups n=97 (10.8%)).

CONCLUSIONS: This study could not show non-inferiority of expectant management compared with induction of labour in women with uncomplicated pregnancies at 41 weeks; instead a significant difference of 1.4% was found for risk of adverse perinatal outcomes in favour of induction, although the chances of a good perinatal outcome were high with both strategies and the incidence of perinatal mortality, Apgar score <4 at five minutes, and NICU admission low.

TRIAL REGISTRATION: Netherlands Trial Register NTR3431.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Keulen JK, Bruinsma A, Kortekaas JC, et al. Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial. BMJ. 2019. PMID: 30786997. doi:10.1136/bmj.l344

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。